APO Research
Talk to an analyst

APO RESEARCH · REPORT

Prescription Gastrointestinal Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Prescription Gastrointestinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025184 pages

Choose your research edition.

Industry ResearchPrescription Gastrointestinal Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Prescription Gastrointestinal Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Prescription Gastrointestinal Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prescription Gastrointestinal Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Prescription Gastrointestinal Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Prescription Gastrointestinal Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Prescription Gastrointestinal Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Prescription Gastrointestinal Drugs include Eisai, Merck, GlaxoSmithKline, AstraZeneca, Salix Pharmaceuticals and Axcan Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Prescription Gastrointestinal Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Prescription Gastrointestinal Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Prescription Gastrointestinal Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Prescription Gastrointestinal Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Prescription Gastrointestinal Drugs Segment by Company

Eisai

Merck

GlaxoSmithKline

AstraZeneca

Salix Pharmaceuticals

Axcan Pharmaceuticals

Prescription Gastrointestinal Drugs Segment by Type

Oral

Topical

Prescription Gastrointestinal Drugs Segment by Application

Online Pharmacies

Hospital Pharmacies

Retail Pharmacies

Prescription Gastrointestinal Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prescription Gastrointestinal Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prescription Gastrointestinal Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prescription Gastrointestinal Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Prescription Gastrointestinal Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Prescription Gastrointestinal Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Prescription Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Prescription Gastrointestinal Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Prescription Gastrointestinal Drugs Industry Trends Table 2. Prescription Gastrointestinal Drugs Industry Drivers Table 3. Prescription Gastrointestinal Drugs Industry Opportunities and Challenges Table 4. Prescription Gastrointestinal Drugs Industry Restraints Table 5. Global Prescription Gastrointestinal Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Prescription Gastrointestinal Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Prescription Gastrointestinal Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Prescription Gastrointestinal Drugs Sales Market Share by Manufacturers Table 9. Global Prescription Gastrointestinal Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Prescription Gastrointestinal Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Prescription Gastrointestinal Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Prescription Gastrointestinal Drugs Manufacturers, Product Type & Application Table 13. Global Prescription Gastrointestinal Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Prescription Gastrointestinal Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Topical Table 18. Global Prescription Gastrointestinal Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Prescription Gastrointestinal Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Prescription Gastrointestinal Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2026) Table 22. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2027-2032) Table 23. Global Prescription Gastrointestinal Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Prescription Gastrointestinal Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Prescription Gastrointestinal Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Online Pharmacies Table 29. Major Manufacturers of Hospital Pharmacies Table 30. Major Manufacturers of Retail Pharmacies Table 31. Global Prescription Gastrointestinal Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Prescription Gastrointestinal Drugs Sales by Application (2021-2026) & (k units) Table 33. Global Prescription Gastrointestinal Drugs Sales by Application (2027-2032) & (k units) Table 34. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2026) Table 35. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2027-2032) Table 36. Global Prescription Gastrointestinal Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Prescription Gastrointestinal Drugs Revenue by Application (2021-2026) & (k units) Table 38. Global Prescription Gastrointestinal Drugs Revenue by Application (2027-2032) & (k units) Table 39. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026) & (k units) Table 43. Global Prescription Gastrointestinal Drugs Sales Market Share by Region (2021-2026) Table 44. Global Prescription Gastrointestinal Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Prescription Gastrointestinal Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 48. North America Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 49. Europe Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 51. Europe Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country (2027-2032) & (k units) Table 58. Global Prescription Gastrointestinal Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Prescription Gastrointestinal Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Prescription Gastrointestinal Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2027-2032) Table 63. Eisai Company Information Table 64. Eisai Business Overview Table 65. Eisai Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Eisai Prescription Gastrointestinal Drugs Product Portfolio Table 67. Eisai Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Prescription Gastrointestinal Drugs Product Portfolio Table 72. Merck Recent Development Table 73. GlaxoSmithKline Company Information Table 74. GlaxoSmithKline Business Overview Table 75. GlaxoSmithKline Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio Table 77. GlaxoSmithKline Recent Development Table 78. AstraZeneca Company Information Table 79. AstraZeneca Business Overview Table 80. AstraZeneca Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio Table 82. AstraZeneca Recent Development Table 83. Salix Pharmaceuticals Company Information Table 84. Salix Pharmaceuticals Business Overview Table 85. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 87. Salix Pharmaceuticals Recent Development Table 88. Axcan Pharmaceuticals Company Information Table 89. Axcan Pharmaceuticals Business Overview Table 90. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio Table 92. Axcan Pharmaceuticals Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Prescription Gastrointestinal Drugs Distributors List Table 96. Prescription Gastrointestinal Drugs Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Prescription Gastrointestinal Drugs Product Image Figure 2. Global Prescription Gastrointestinal Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prescription Gastrointestinal Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Prescription Gastrointestinal Drugs Sales (2021-2032) & (k units) Figure 5. Global Prescription Gastrointestinal Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Prescription Gastrointestinal Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Topical Image Figure 10. Global Prescription Gastrointestinal Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Prescription Gastrointestinal Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Prescription Gastrointestinal Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Prescription Gastrointestinal Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2032) Figure 16. Online Pharmacies Image Figure 17. Hospital Pharmacies Image Figure 18. Retail Pharmacies Image Figure 19. Global Prescription Gastrointestinal Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Prescription Gastrointestinal Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Prescription Gastrointestinal Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Prescription Gastrointestinal Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Prescription Gastrointestinal Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Prescription Gastrointestinal Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Prescription Gastrointestinal Drugs Sales Market Share by Country (2021-2032) Figure 39. China Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Prescription Gastrointestinal Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Prescription Gastrointestinal Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Prescription Gastrointestinal Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Prescription Gastrointestinal Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Prescription Gastrointestinal Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Topical
Applications
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Eisai
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Salix Pharmaceuticals
  • Axcan Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Prescription Gastrointestinal Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Prescription Gastrointestinal Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Prescription Gastrointestinal Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Prescription Gastrointestinal Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Prescription Gastrointestinal Drugs Market Dynamics
  1. 2.1 Prescription Gastrointestinal Drugs Industry Trends
  2. 2.2 Prescription Gastrointestinal Drugs Industry Drivers
  3. 2.3 Prescription Gastrointestinal Drugs Industry Opportunities and Challenges
  4. 2.4 Prescription Gastrointestinal Drugs Industry Restraints
3 Prescription Gastrointestinal Drugs Market by Manufacturers
  1. 3.1 Global Prescription Gastrointestinal Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Prescription Gastrointestinal Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Prescription Gastrointestinal Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Prescription Gastrointestinal Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Prescription Gastrointestinal Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Prescription Gastrointestinal Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Prescription Gastrointestinal Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Prescription Gastrointestinal Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Prescription Gastrointestinal Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Prescription Gastrointestinal Drugs Tier 1, Tier 2, and Tier 3
4 Prescription Gastrointestinal Drugs Market by Type
  1. 4.1 Prescription Gastrointestinal Drugs Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Topical
  4. 4.2 Global Prescription Gastrointestinal Drugs Sales by Type
  5. 4.2.1 Global Prescription Gastrointestinal Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Prescription Gastrointestinal Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Prescription Gastrointestinal Drugs Revenue by Type
  9. 4.3.1 Global Prescription Gastrointestinal Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Prescription Gastrointestinal Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Type (2021-2032)
5 Prescription Gastrointestinal Drugs Market by Application
  1. 5.1 Prescription Gastrointestinal Drugs Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Prescription Gastrointestinal Drugs Sales by Application
  6. 5.2.1 Global Prescription Gastrointestinal Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prescription Gastrointestinal Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Prescription Gastrointestinal Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Prescription Gastrointestinal Drugs Revenue by Application
  10. 5.3.1 Global Prescription Gastrointestinal Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Prescription Gastrointestinal Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Prescription Gastrointestinal Drugs Revenue Market Share by Application (2021-2032)
6 Global Prescription Gastrointestinal Drugs Sales by Region
  1. 6.1 Global Prescription Gastrointestinal Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Prescription Gastrointestinal Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Prescription Gastrointestinal Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Prescription Gastrointestinal Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Prescription Gastrointestinal Drugs Revenue by Region
  1. 7.1 Global Prescription Gastrointestinal Drugs Revenue by Region
  2. 7.1.1 Global Prescription Gastrointestinal Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Prescription Gastrointestinal Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Prescription Gastrointestinal Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Prescription Gastrointestinal Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Prescription Gastrointestinal Drugs Revenue (2021-2032)
  8. 7.2.2 North America Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Prescription Gastrointestinal Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Prescription Gastrointestinal Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Prescription Gastrointestinal Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Prescription Gastrointestinal Drugs Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Prescription Gastrointestinal Drugs Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Prescription Gastrointestinal Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Prescription Gastrointestinal Drugs Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Salix Pharmaceuticals
  26. 8.5.1 Salix Pharmaceuticals Company Information
  27. 8.5.2 Salix Pharmaceuticals Business Overview
  28. 8.5.3 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Salix Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  30. 8.5.5 Salix Pharmaceuticals Recent Developments
  31. 8.6 Axcan Pharmaceuticals
  32. 8.6.1 Axcan Pharmaceuticals Company Information
  33. 8.6.2 Axcan Pharmaceuticals Business Overview
  34. 8.6.3 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Axcan Pharmaceuticals Prescription Gastrointestinal Drugs Product Portfolio
  36. 8.6.5 Axcan Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Prescription Gastrointestinal Drugs Value Chain Analysis
  2. 9.1.1 Prescription Gastrointestinal Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Prescription Gastrointestinal Drugs Production Mode & Process
  6. 9.2 Prescription Gastrointestinal Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Prescription Gastrointestinal Drugs Distributors
  9. 9.2.3 Prescription Gastrointestinal Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst